Benzocaine-loaded polymeric nanocapsules: Study of the anesthetic activities

Journal of Pharmaceutical Sciences

Volumn 101, Issue 3, 2012, Pages 1157-1165

  Silva de Melo, Nathalie Ferreira ^a,b   de Araújo, Daniele Ribeiro ^c   Grillo, Renato ^a,b   Moraes, Carolina Morales ^a   de Matos, Angélica Prado ^a   de Paula, Eneida ^a   Rosa, André Henrique ^b   Fraceto, Leonardo Fernandes ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Analgesia; Benzocaine; Biodegradable polymers; Controlled release; In vivo; Local anesthetic; Nanocapsules; Nanotechnology; PLA); Poly(lactic glycolic) acid (PLGA; Polymeric nanocapsule

Indexed keywords

BENZOCAINE; NANOCAPSULE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG RELEASE; ENCAPSULATION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARTICLE SIZE; PH; SCIATIC NERVE; ZETA POTENTIAL;

EID: 84855890223     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22829     Document Type: Article

References (50)

1. Covino BG, Vassalo HG. 1985. Anestésicos locais: Mecanismos de ação e uso clínico. Rio de Janeiro, Brazil: Colina Editora.
2. +channel. Biophys Chem 123(1):29-39.
3. de Araújo DR, de Paula E, Fraceto LF. 2008. Anestésicos locais: Interação com membranas biológicas e com o canal de sódio voltagem-dependente. Quim Nova 31(7):1775-1783.
4. Fraceto LF, Moraes CM, Gonçalves MM, de Araújo DR, Zanella L, de Paula E, Pertinhez TA. 2007. Caracterização do complexo de inclusão ropivacaína: Beta-ciclodextrina. Quim Nova 30(5):1203-1207.
5. de Jong RH. 1994. Local anesthetics. 1st ed. Springfield, Illinois: C. C. Thomas.
6. So TY, Farrington E. 2008. Topical benzocaine-induced methemoglobinemia in the pediatric population. J Pediatr Health Care 22(6):335-339.
7. Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. 1999. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release 57(3):259-268.
8. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. 1999. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 57(2):171-185.
9. Govender, T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, Davis SS. 2000. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm 199(1):95-110.
10. Polakovic M, Gorner T, Gref R, Dellacherie E. 1999. Lidocaine loaded biodegradable nanospheres II. Modelling of drug release. J Control Release 60(2-3):169-177.
11. Moraes CM, de Matos AP, de Paula E, Rosa AH, Fraceto LF. 2009. Benzocaine loaded biodegradable poly-(d, l-lactide-co-glycolide) nanocapsules: Factorial design and characterization. Mater Sci Eng B 165(3):243-246.
12. Grillo R, Melo NFS, de Araújo DR, de Paula E, Rosa AH, Fraceto LF. 2010. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J Drug Target 18(9):688-699.
13. Melo NFS, Grillo R, Rosa AH, Dias Filho NL, de Paula E, de Araújo DR, Fraceto LF. 2010. Desenvolvimento e caracterização de nanocápsulas de poli(l-lactideo) contendo benzocaína. Quim Nova 33(1):65-69.
14. Melo NFS, Grillo R, Guilherme VA, de Araujo DR, de Paula E, Rosa AH, Fraceto LF. 2011. Poly(lactide-co-glycolide) nanocapsules containing benzocaine: Influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm Res 28:1984-1994.
15. Moinard-Checot D, Chevalier Y, Briancon S, Fessi H, Guinebretiere S. 2006. Nanoparticles for drug-delivery: Review of the formulation and process difficulties illustrated by the emulsion-diffusion process. J Nanosci Nanotechnol 6(9-10):2664-2681.
16. Vauthier C, Couvreur P. 2007. Nanomedicines: A new approach for the treatment of serious deseases. J Biomed Nanotechnol 3(3):223-234.
17. Mora-Huertas CE, Fessi H, Elaissari A. 2010. Polymer based nanocapsules for drug delivery. Int J Pharm 385(1-2):113-142.
18. Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. 2006. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir 22(9):4397-4402.
19. Pohlmann AR, Weiss V, Mertins O, Silveira NP, Guterres SS. 2002. Sprayed-dried indomethacin-loaded polyester nanocapsules and nanospheres: Development, stability and nanostructure models. Eur J Pharm Sci 16(4-5):305-312.
20. Pohlmann AR, Mezzalira G, Venturini CG, Cruz L, Bernardi A, Jager E, Battastini AMO, da Silveira NP, Guterres SS. 2008. Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspension: A relation between light scattering and drug content. Int J Pharm 359(1-2): 288-293.
21. Fessi H, Puiseiux F, Devissaguet J-P, Ammoury N, Benita S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55:R1-R4.
22. Budhian A, Siegel SJ, Winey KI. 2007. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm 336(2):367-375.
23. Duran N, Mattoso LHC, Morais PC. 2006. Nanotecnologia: Introdução, preparação e caracterização de nanomateriais e exemplos de aplicação. 1st ed.São Paulo, Brazil: Artliber.
24. Morales MM. 2007. Terapias avançadas-Céluas-tronco, terapia gênica e nanotecnologia aplicada à saúde. 1st ed. São Paulo, Brazil: Atheneu.
25. Picos DR, Carril MG, Mena DF, Fuente LN. 2000. Microesferas biodegradables de liberación controlada para administración parenteral. Rev Cubana Farm 34(1):70-77.
26. Ginosar Y, Davidson EM, Firman N, Meroz Y, Lemmens H, Weiniger CF. 2010. A randomized controlled trial using patient-controlled epidural analgesia with 0.25% versus 0.0625% bupivacaine in nulliparous labor: Effect on analgesia requeriment and maternal satisfaction. Int J Obstet Anesth 19(2):171-178.
27. Nair LS, Laurencin CT. 2007. Biodegradable polymers as biomaterials. Prog Polym Sci 32(8-9):762-798.
28. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. 2004. Poly-ε-caprolactone microspheres and nanospheres: An overview. Int J Pharm 278(1):1-23.
29. Wu XS. 1995. Synthesis and properties of biodegradable lactic/glycolic acid polymers. In Encyclopedic handbook of biomaterials and bioengineering, Part A: Materials; Wise DL, Ed. New York: Marcel Dekker.
30. Luderer F, Lober M, Rohm HW, Gocke C, Kunna K, Kock K, Kroemer HK, Weitschies W, Schimitz KP, Sternberg K. 2011. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application. J Biomater Appl 25(8):851-875.
31. Moraes CM, Matos AP, Grillo R, Melo NFS, de Paula E, Dias Filho NL, Rosa AH, Fraceto LF. 2010. Screening of formulation variables for the preparation of poly(ε-caprolactone) nanocapsules containing the local anesthetic benzocaine. J Nanosci Nanotechnol 11(3):2450-2457.
32. Riley T, Govender T, Stolnik S, Xiong CD, Garnett MC, Illum L, Davis SS. 1999. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids Surf B 16(1-4):147-159.
33. Jie P, Venkatraman SS, Min F, Freddy BYC, Huat GL. 2005. Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier. J Control Release 110(1):20-33.
34. International Conference on Harmonization, guidance for industry-Q2B. 1996. Validation of analytical procedures: Methodology. London, UK: International Conference on Harmonization.
35. Agência Nacional de Vigilância Sanitária. 2003. Resolution RE no. 899; May 29, 2003; Brazil.
36. Paavola A, Yliruusi J, Kajimoto Y, Kalso E, Wahlstrom T, Rosenberg P. 1995. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res 12(12):1997-2002.
37. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15(1):25-35.
38. Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60(4):110-111.
39. Costa P, Lobo JMS. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13(2):123-133.
40. Leszczynka K, Kau ST. 1992. A sciatic nerve blockade method to differentiate drug-induced local anesthesia from neuromuscular blockade in mice. J Pharmacol Toxicol Methods 27(2):85-93.
41. Gantenbein M, Attolini L, Bruguerolle B. 1996. Potassium channel agonists modify the local anesthetic activity of bupivacaine in mice. Can J Anaesth 43(8):871-876.
42. Randall LO, Selitto JJ. 1957. A method for measurement of analgesic activity of inflamed tissue. Arch Int Pharmacodyn Ther 111(1):409-419.
43. de Araújo DR, Fraceto LF, Braga AFA, de Paula E. 2005. Sistemas de liberação controlada com bupivacaína racêmica (S50-R50) e mistura enantiomérica de bupivacaína (S75-R25): Efeitos da complexação com ciclodextrinas no bloqueio do nervo ciático em camundongos. Rev Bras Anestesiol 55(3):316-328.
44. Pinto LMA, Yokaichiya DK, Fraceto LF, de Paula E. 2000. Interaction of benzocaine with model membranes. Biophys Chem 87(2-3):213-223.
45. Guterres SS, Fessi H, Barrat G, Devissaguet J-P, Puisieux F. 1995. Poly (dl-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int J Pharm 113(1):57-63.
46. Moraes CM, de Matos AP, Lima R, Rosa AH, de Paula E, Fraceto LF. 2007. Initial development and characterization of PLGA nanospheres containing ropivacaine. J Biol Phys 33(5-6):455-461.
47. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1-2):1-20.
48. Venkatraman SS, Jie P, Min F, Freddy BYC, Leong-Huat G. 2005. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. Int J Pharm 298(1):219-232.
49. Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Ravi Kumar MNV. 2007. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 24(5):899-908.
50. Sinnott CJ, Strichartz GR. 2003. Levobupivacaine versus ropivacaine for sciatic nerve block in the rat. Reg Anesth Pain Med 28(4):294-303.